Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc., commonly referred to as Accelerate, is a leading innovator in the field of diagnostic solutions, headquartered in the United States. Founded in 2012, the company has rapidly established itself within the medical diagnostics industry, focusing primarily on the development of advanced technologies for the rapid detection of infectious diseases. With a strong presence in major operational regions across North America and Europe, Accelerate's core products, including the Accelerate Pheno™ system, stand out for their ability to deliver precise results in a fraction of the time compared to traditional methods. This unique capability not only enhances patient care but also optimises antibiotic stewardship. Recognised for its commitment to improving clinical outcomes, Accelerate Diagnostics has achieved significant milestones, positioning itself as a key player in the market for rapid diagnostic solutions.
DitchCarbon Score
How does Accelerate Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Accelerate Diagnostics, Inc.'s score of 23 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Accelerate Diagnostics, Inc.'s reported carbon emissions
In 2023, Accelerate Diagnostics, Inc. reported total carbon emissions of approximately 6,800,000,000 kg CO2e across all scopes. This includes Scope 1 emissions of about 113,528,000 kg CO2e, Scope 2 emissions of approximately 139,701,000 kg CO2e, and significant Scope 3 emissions, which accounted for the majority of their footprint at 6,800,000,000 kg CO2e. In 2022, the company also reported Scope 3 emissions of 6,800,000,000 kg CO2e, indicating a consistent level of emissions in this category. However, there are no disclosed reduction targets or specific climate pledges from Accelerate Diagnostics, Inc. at this time. The absence of formal reduction initiatives suggests that the company may be in the early stages of developing a comprehensive climate strategy. As a company headquartered in the US, Accelerate Diagnostics, Inc. operates within an industry context that increasingly prioritises sustainability and carbon footprint reduction.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Get Started| 2022 | 2023 | |
|---|---|---|
| Scope 1 | - | 000,000,000 |
| Scope 2 | - | 000,000,000 |
| Scope 3 | 6,800,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Accelerate Diagnostics, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
